Loading…
Transparency in Drug Labeling Act
Legislative Progress
Introduced
September 26, 2008
Latest Action
September 26, 2008
Primary Sponsor
Sherrod BrownDemocratic(OH)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2008 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R. 3610, Food and Drug Import Safety Act of 2007; H.R.3967, Imported Food Safety Improvement Act of 2007; S. 654, Safe Food Act of 2007; S. 1776, Imported Food Security Act of 2007; H.R. 3624, Consumer Food Safety Act of 2007; H.R. 5409, Safe Food Enforcement Assessment Standards and Targeting Act of 2008; H.R. 5839, Safeguarding America's Pharmaceutical Act of 2008 S.3385 FDA Food Safety Modernization Act S.3409 Drug and Device Accountability Act S.3422 Food Tracking Improvement Bill S.3633 Transparency in Drug Labeling act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $995,422 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2008 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 493, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. H.R. 1443, to treat arbitration clauses which are unilaterally imposed on consumers as an unfair and deceptive trade practice . H.R. 1685, to protect information relating to consumers, to require notice of security breaches, and for other purposes. H.R. 2099, to authorize the secretary of HHS to order a mandatory recall of any product that is regulated by the FDA. H.R. 2124, to strengthen requirements related to security breaches of data involving the disclosure of sensitive personal information. HR 2718, DSHEA Full Implementation and Enforcement Act of 2007. H.R. 3100, to amend the Federal Food, Drug, and Cosmetic Act and the Consumer Product Safety Act to increase the safety of food, toothpaste, and toys. H.R. 3588, to amend the Consumer Product Safety Act to provide the Consumer Product Safety Commission with greater authority to require recalls, mandatory routine product testing, and for other purposes. H.R. 3580, the Food and Drug Administration Amendments Act of 2007. HR 4030, To prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. H.R. 4040, Consumer Product Safety Modernization Act. H.R. 5636, to establish a comprehensive process to inform American consumers about food and product recalls, and for other purposes; to Energy & Commerce. H.R. 5769, to direct the Federal Trade Commission to revise the Telemarketing Sales Rule to explicitly prohibit the sending of a text message containing an unsolicited advertisement to a cellular telephone number listed on the national do-not-call registry; to Energy & Commerce. S. 358, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. S. 1082, the Food and Drug Administration Revitalization Act. S. 1178, to strengthen data protection and safeguards, require data breach notification, and further prevent identity theft. S. 1260, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 2256, to establish an office of international and domestic product safety and a product safety coordinating council to improve the management, coordination, promotion, and oversight of product safety responsibilities, develop a centralized public database for product recalls, advisories, and alerts, and for other purposes. S. 2275, to prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates, and for other purposes. S. 2663, to reform the Consumer Product Safety Commission to provide greater protection for children's products, to improve the screening of noncompliant consumer products, to improve the effectiveness of consumer product recall programs, and for other purposes; read the first time. S. 2794, to protect older Americans from misleading and fraudulent marketing practices, with the goal of increasing retirement security; to Judiciary. S. 3086, to amend the antitrust laws to ensure competitive market-based fees and terms for merchants' access to electronic payment systems. S. 3425, to make effective the proposed rule of the Food and Drug Administration relating to sunscreen drug products, and for other purposes. S. 3475, to amend the Federal Food, Drug, and Cosmetic Act to require manufacturers of bottled water to submit annual reports, and for other purposes. S. 3633, to amend the Federal Food, Drug, and Cosmetic Act to require country of origin labeling on prescription and over-the-counter drugs. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States. S. 3108, to require the president to call a White House conference on food and nutrition. S. 3385, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply. S. 3422, to amend the Federal Food, Drug, and Cosmetic Act to provide for the establishment of a traceability system for food, and for other purposes. S. 3575, to amend the Federal Food, Drug, and Cosmetic Act with respect to nutrition labeling of food offered for sale in food service establishments. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes. H.R. 6127, to require the president to call a White House conference on food and nutrition. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes. H.R. 7120, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution and citation of scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 7143, to establish the Food Safety Administration within the Department of Health and Human Services to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination, and for other purposes.
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · third_quarter · Consumer Issues/Safety/Products
H.R. 493, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. H.R. 1443, to treat arbitration clauses which are unilaterally imposed on consumers as an unfair and deceptive trade practice . H.R. 1685, to protect information relating to consumers, to require notice of security breaches, and for other purposes. H.R. 2099, to authorize the secretary of HHS to order a mandatory recall of any product that is regulated by the FDA. H.R. 2124, to strengthen requirements related to security breaches of data involving the disclosure of sensitive personal information. HR 2718, DSHEA Full Implementation and Enforcement Act of 2007. H.R. 3100, to amend the Federal Food, Drug, and Cosmetic Act and the Consumer Product Safety Act to increase the safety of food, toothpaste, and toys. H.R. 3588, to amend the Consumer Product Safety Act to provide the Consumer Product Safety Commission with greater authority to require recalls, mandatory routine product testing, and for other purposes. H.R. 3580, the Food and Drug Administration Amendments Act of 2007. HR 4030, To prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. H.R. 4040, Consumer Product Safety Modernization Act. H.R. 5636, to establish a comprehensive process to inform American consumers about food and product recalls, and for other purposes; to Energy & Commerce. H.R. 5769, to direct the Federal Trade Commission to revise the Telemarketing Sales Rule to explicitly prohibit the sending of a text message containing an unsolicited advertisement to a cellular telephone number listed on the national do-not-call registry; to Energy & Commerce. S. 358, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. S. 1082, the Food and Drug Administration Revitalization Act. S. 1178, to strengthen data protection and safeguards, require data breach notification, and further prevent identity theft. S. 1260, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 2256, to establish an office of international and domestic product safety and a product safety coordinating council to improve the management, coordination, promotion, and oversight of product safety responsibilities, develop a centralized public database for product recalls, advisories, and alerts, and for other purposes. S. 2275, to prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates, and for other purposes. S. 2663, to reform the Consumer Product Safety Commission to provide greater protection for children's products, to improve the screening of noncompliant consumer products, to improve the effectiveness of consumer product recall programs, and for other purposes; read the first time. S. 2794, to protect older Americans from misleading and fraudulent marketing practices, with the goal of increasing retirement security; to Judiciary. S. 3086, to amend the antitrust laws to ensure competitive market-based fees and terms for merchants' access to electronic payment systems. S. 3425, to make effective the proposed rule of the Food and Drug Administration relating to sunscreen drug products, and for other purposes. S. 3475, to amend the Federal Food, Drug, and Cosmetic Act to require manufacturers of bottled water to submit annual reports, and for other purposes. S. 3633, to amend the Federal Food, Drug, and Cosmetic Act to require country of origin labeling on prescription and over-the-counter drugs. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States. S. 3108, to require the president to call a White House conference on food and nutrition. S. 3385, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply. S. 3422, to amend the Federal Food, Drug, and Cosmetic Act to provide for the establishment of a traceability system for food, and for other purposes. S. 3575, to amend the Federal Food, Drug, and Cosmetic Act with respect to nutrition labeling of food offered for sale in food service establishments. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes. H.R. 6127, to require the president to call a White House conference on food and nutrition. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes. H.R. 7120, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution and citation of scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 7143, to establish the Food Safety Administration within the Department of Health and Human Services to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination, and for other purposes.
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · fourth_quarter · Budget/Appropriations
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008
Client expense: $3,250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Health Issues
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
Client expense: $6,170,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · third_quarter · Budget/Appropriations
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008
Client expense: $3,070,000 · Firm income: Not reported
2008 · third_quarter · Budget/Appropriations
H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008
Client expense: $3,060,000 · Firm income: Not reported
2008 · third_quarter · Consumer Issues/Safety/Products
H.R. 493, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. H.R. 1443, to treat arbitration clauses which are unilaterally imposed on consumers as an unfair and deceptive trade practice . H.R. 1685, to protect information relating to consumers, to require notice of security breaches, and for other purposes. H.R. 2099, to authorize the secretary of HHS to order a mandatory recall of any product that is regulated by the FDA. H.R. 2124, to strengthen requirements related to security breaches of data involving the disclosure of sensitive personal information. HR 2718, DSHEA Full Implementation and Enforcement Act of 2007. H.R. 3100, to amend the Federal Food, Drug, and Cosmetic Act and the Consumer Product Safety Act to increase the safety of food, toothpaste, and toys. H.R. 3588, to amend the Consumer Product Safety Act to provide the Consumer Product Safety Commission with greater authority to require recalls, mandatory routine product testing, and for other purposes. H.R. 3580, the Food and Drug Administration Amendments Act of 2007. HR 4030, To prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates. H.R. 4040, Consumer Product Safety Modernization Act. H.R. 5636, to establish a comprehensive process to inform American consumers about food and product recalls, and for other purposes; to Energy & Commerce. H.R. 5769, to direct the Federal Trade Commission to revise the Telemarketing Sales Rule to explicitly prohibit the sending of a text message containing an unsolicited advertisement to a cellular telephone number listed on the national do-not-call registry; to Energy & Commerce. S. 358, to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. S. 1082, the Food and Drug Administration Revitalization Act. S. 1178, to strengthen data protection and safeguards, require data breach notification, and further prevent identity theft. S. 1260, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 2256, to establish an office of international and domestic product safety and a product safety coordinating council to improve the management, coordination, promotion, and oversight of product safety responsibilities, develop a centralized public database for product recalls, advisories, and alerts, and for other purposes. S. 2275, to prohibit the manufacture, sale, or distribution in commerce of certain children's products and child care articles that contain phthalates, and for other purposes. S. 2663, to reform the Consumer Product Safety Commission to provide greater protection for children's products, to improve the screening of noncompliant consumer products, to improve the effectiveness of consumer product recall programs, and for other purposes; read the first time. S. 2794, to protect older Americans from misleading and fraudulent marketing practices, with the goal of increasing retirement security; to Judiciary. S. 3086, to amend the antitrust laws to ensure competitive market-based fees and terms for merchants' access to electronic payment systems. S. 3425, to make effective the proposed rule of the Food and Drug Administration relating to sunscreen drug products, and for other purposes. S. 3475, to amend the Federal Food, Drug, and Cosmetic Act to require manufacturers of bottled water to submit annual reports, and for other purposes. S. 3633, to amend the Federal Food, Drug, and Cosmetic Act to require country of origin labeling on prescription and over-the-counter drugs. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States. S. 3108, to require the president to call a White House conference on food and nutrition. S. 3385, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply. S. 3422, to amend the Federal Food, Drug, and Cosmetic Act to provide for the establishment of a traceability system for food, and for other purposes. S. 3575, to amend the Federal Food, Drug, and Cosmetic Act with respect to nutrition labeling of food offered for sale in food service establishments. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes. H.R. 6127, to require the president to call a White House conference on food and nutrition. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes. H.R. 7120, to amend the Federal Food, Drug, and Cosmetic Act concerning the distribution and citation of scientific research in connection with foods and dietary supplements, and for other purposes. H.R. 7143, to establish the Food Safety Administration within the Department of Health and Human Services to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination, and for other purposes.
2008 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 3610, Food and Drug Import Safety Act of 2007; H.R.3967, Imported Food Safety Improvement Act of 2007; S. 654, Safe Food Act of 2007; S. 1776, Imported Food Security Act of 2007; H.R. 3624, Consumer Food Safety Act of 2007; H.R. 5409, Safe Food Enforcement Assessment Standards and Targeting Act of 2008; H.R. 5839, Safeguarding America's Pharmaceutical Act of 2008 S.3385 FDA Food Safety Modernization Act S.3409 Drug and Device Accountability Act S.3422 Food Tracking Improvement Bill S.3633 Transparency in Drug Labeling act
Client expense: $794,730 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2008 · third_quarter · Health Issues
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1014, Heart Disease Education, Analysis Research, and Treatment for Women Act: reporting and analysis of patient data H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5683, The Government Accountability Office Act: disclosure of data H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: direct-to-consumer drug advertising H.R. 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008: on-line pharmacy issues H.R. 6378, Strengthening of FDA Integrity Act of 2008: debarment H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6388 The Government Accountability Office Improvement Act of 2008: disclosure of data H.R. 6432, Animal Drug User Fee Amendments of 2008: technical corrections to FDAAA H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: $5,420,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)